Are non-prescription medications needed for weight control?

被引:18
作者
Bray, George A. [1 ]
机构
[1] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA
关键词
D O I
10.1038/oby.2007.100
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
At any one time large numbers of people are attempting to control their weight. Women are the principal consumers of weight-control programs. Their options, outside the prescription drug market and surgical treatment, include diets and diet books, exercise alone or with supervision in exercise facilities, dietary supplements, group programs, doctors, dietitians, psychologists, and other health-care professionals. Non-prescription products available to help people control their weight cover a wide range, including herbal dietary supplements, diet drinks and portion-controlled foods, meal replacements, and low-carbohydrate diets and foods. The introduction of orlistat as an over-the-counter (OTC) product will provide the only Food and Drug Administration (FDA)-approved product for weight loss currently in that category since phenylpropanolamine (PPA) was withdrawn by the FDA. The FDA approval process is considerably more expensive than allowing untested herbal supplements to be marketed without testing, but the added safety evaluation by the FDA will reduce the risk of disastrous outcomes that have plagued many approaches to weight control. Support for a place for orlistat as an OTC product includes the inadequacy of current programs, empowerment of the public, lower cost, and bringing pharmacists into weight-control programs. The downside includes improper use of OTC orlistat that may not result in achieving individual expectations.
引用
收藏
页码:509 / 514
页数:6
相关论文
共 47 条
[1]
Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: A 16 week, double-blind, placebo-controlled trial [J].
Anderson, James W. ;
Schwartz, Susan M. ;
Hauptman, Jonathan ;
Boldrin, Mark ;
Rossi, Maureen ;
Bansal, Vidhu ;
Hale, Cecilia A. .
ANNALS OF PHARMACOTHERAPY, 2006, 40 (10) :1717-1723
[2]
ASTRUP A, 1992, INT J OBESITY, V16, P269
[3]
Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1
[4]
Use of nonprescription dietary supplements for weight loss is common among Americans [J].
Blanck, Heidi Michels ;
Serdula, Mary K. ;
Gillespie, Cathleen ;
Galuska, Deborah A. ;
Sharpe, Patricia A. ;
Conway, Joan M. ;
Kettel, Laura ;
Ainsworth, Barbara E. .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2007, 107 (03) :441-447
[5]
An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial [J].
Boozer, CN ;
Nasser, JA ;
Heymsfield, SB ;
Wang, V ;
Chen, G ;
Solomon, JL .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (03) :316-324
[6]
Medical consequences of obesity [J].
Bray, GA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2583-2589
[7]
Bray GA, 2004, AM J CLIN NUTR, V79, P347
[8]
Obesity is a chronic, relapsing neurochemical disease [J].
Bray, GA .
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (01) :34-38
[9]
A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women [J].
Brehm, BJ ;
Seeley, RJ ;
Daniels, SR ;
D'Alessio, DA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1617-1623
[10]
Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts:: Results from a general population study [J].
Carpenter, KM ;
Hasin, DS ;
Allison, DB ;
Faith, MS .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (02) :251-257